amrinone has been researched along with Blood Poisoning in 2 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jurasinski, CV | 1 |
| Kilpatrick, L | 1 |
| Vary, TC | 2 |
2 other studies available for amrinone and Blood Poisoning
| Article | Year |
|---|---|
Amrinone prevents muscle protein wasting during chronic sepsis.
Topics: Abscess; Adenosine Triphosphate; Amrinone; Animals; Cyclic AMP; Eating; Insulin; Kinetics; Male; Mus | 1995 |
Amrinone prevents the inhibition of muscle pyruvate dehydrogenase complex activity during sepsis.
Topics: Amrinone; Animals; Enzyme Inhibitors; Lactates; Lactic Acid; Least-Squares Analysis; Linear Models; | 1996 |